Murphy Analytics Issues Updated Research Report on Midas Medici

Murphy Analytics Issues Updated Research Report on Midas Medici

New Report Outlines Recent Acquisition of Brazil-based CIMCORP and Targets 12-Month Price of $10.00

PR Newswire

NEW YORK, Sept. 19, 2011 /PRNewswire/ — Midas Medici Group Holdings, Inc. (“Midas”) (OTCBB: MMED), an innovative green IT company in the fields of virtualization, cloud computing and data management, as well as Smart Grid solutions, today announced the release of an in-depth research report update by Patrick Murphy, CFA, principal of fee-based, third-party research firm Murphy Analytics.

In his report, Mr. Murphy discusses Midas Medici, its unique position at the intersection of energy and technology, and initiates coverage with a 12-month price target of $10.00 per share.

“With our recent acquisition, Midas Medici is addressing the increasing demand for IT services, cloud computing and virtualization through our expanding operations across Brazil, the United States and around the world,” stated Nana Baffour, CEO and Co-Founder of Midas. “This comprehensive report provides investors with an excellent overview of Midas Medici’s unique strengths: from our strategic clients and relationships in Brazil, our comprehensive understanding of the energy and technology sectors, as well as our significant potential for expansion through further accretive acquisitions.”

From the Murphy Analytics Research Report, Mr. Murphy states:

“While organic revenue growth and margin improvement helped Midas continue the positive trend towards profitability, the acquisition of CIMCORP illustrates the magnitude of the opportunity for the Company’s acquisition strategy. CIMCORP greatly expands the Company’s reach into South America and provides Midas with access to an IT market where industry titans such as IBM, CISCO and others are enjoying double digit growth that far exceeds the growth experienced in markets such as North America and Europe.”

The report details the significant growth projected in cloud computing, data centers and virtualization in Brazil, which is one of the fastest growing BRIC countries in terms of IT technology, and how this IT infrastructure spending is being further compounded by the country’s preparations for the World Cup in 2014 and Olympics in 2016. Murphy Analytics also explains how Midas Medici is attempting to translate this growth into future results utilizing its unique specialized services and cross-border revenue opportunities.

The complete report is available in Acrobat format, free of charge:

http://www.murphyanalytics.com/uploads/MMED_Update.pdf

About Midas Medici Group Holdings, Inc.

Midas Medici Group Holdings, Inc. (OTCBB: MMED) is a green IT company that supplies mid-sized and select enterprises and institutions with leading-edge IT solutions in the fields of virtualization, cloud computing and data management, as well as working with utilities and other institutions to transform the electric grid through digital technologies in the United States and Brazil. Across its CIMCORP, Consonus and UtiliPoint brands, Midas works with its customers by optimizing IT and data center investments, cutting energy usage and preventing data loss, all while maximizing productivity. Through a management team with decades of experience, Midas is positioning itself to take advantage of the high-growth IT industry through its unique specialized services at the intersection of energy and technology.

For comprehensive investor relations material, including fact sheets, presentations conference calls and video, please follow the appropriate link: Investor Presentation, Investor Portal, Research Report and Overview Video.

For more information on Midas Medici, please visit: www.midasmedici.com.

Information Regarding the Murphy Analytics Report

SEC Section 17(b) Disclosure: Murphy Analytics has been paid $3,000 by Midas Medici Group Holdings, Inc. Although the Murphy Analytics report described herein was commissioned and paid for by Midas Medici, the company notes that the report was generated independently by Mr. Murphy, and statements by Mr. Murphy are his own and not attributable to Midas Medici. Readers are advised to review the report in its entirety, including the disclosures and disclaimers noted therein.

Safe Harbor Statement

This release contains certain “forward-looking statements” relating to the business of the Company and its subsidiary companies. All statements, other than statements of historical fact included herein are “forward-looking statements” including statements regarding: the Company’s business and operations; business strategy, plans and objectives of the Company and its subsidiaries; and any other statements of non-historical information. These forward-looking statements are often identified by the use of forward-looking terminology such as “believes,” “expects” or similar expressions, involve known and unknown risks and uncertainties. Although the Company believes that the expectations reflected in these forward-looking statements are reasonable, they do involve assumptions, risks and uncertainties, and these expectations may prove to be incorrect. Investors should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company’s actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including those discussed in the Company’s periodic reports that are filed with the Securities and Exchange Commission and available on its website (http://www.sec.gov). All forward-looking statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by these factors. Other than as required under the securities laws, the Company does not assume a duty to update these forward-looking statements.

Company Contact:

Johnson Kachidza
Chief Financial Officer
212-792-0920

Investor Contact:

Trilogy Capital Partners
Darren Minton, President
Toll-free: 800-592-6067
info@trilogy-capital.com

SOURCE Midas Medici Group Holdings, Inc.

Be the first to comment

Leave a Reply